Zimmer Durom Cup Lawsuit Results in $9.2M Verdict Over Failed Hip Implant

A Los Angeles jury has awarded $9.2 million to a man who experienced problems with a Zimmer Durom Cup hip replacement system, which is the first verdict out of several hundred cases pending over the hip implant.  

The Zimmer Durom Cup is an artificial hip replacement system that was first introduced in the United States in 2006, with a design that was supposed to avoid many problems associated with traditional hip replacement components, such as instability, limited range of motion and wear of the bearing.  However, shortly after it was introduced, concerns emerged about a high number of hip replacement failures, where the component loosened and required revision surgery.

A temporary Zimmer Durom Cup recall was issued in July 2008, so that revisions could be made to the product’s warnings and instructions to ensure that doctors were properly trained on the surgical techniques needed to implant the artificial hip correctly.

Learn More About

Hip Replacements Lawsuits

Lawsuits are being reviewed for several different dangerous and defective hip replacement systems.

Learn More See If You Qualify For Compensation

The verdict came in a lawsuit brought by Gary Kline, 59, who experienced problems after receiving the Durom implant.

Following a three week trial and three and a half hours of deliberations, a Los Angeles Superior Court jury awarded Kline $6.4 million for future noneconomic damages, $2.6 million for past noneconomic damages and $153,000 for medical costs, finding that Zimmer was guilty of failure to warn and negligent design of a defective product.

Approximately 12,000 individuals had the Zimmer Durom Cup hip system implanted between 2006 and 2008.  While Zimmer’s own estimates in 2008 suggested that some doctors experienced failure rates as high as 5.7%, some claims have suggested that the between 20% and 30% of people may experience premature problems with the implant.

Most of the Zimmer Durom Cup litigation is pending in the federal court system, were at least 300 cases are currently consolidated as part of an MDL, or Multidistrict Litigation, which is centralized in the District of New Jersey.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.